Bitrobius Genetics Seed

2 known investors

Bitrobius Genetics is developing Gentrafix, a plasmid-based technology that delivers DNA into human cells and spreads it to adjacent cells to replace mutated genes. The company is building gene therapies for genetic diseases, including mitochondrial gene disorders that currently lack treatments.